United Therapeutics Corp. (UTHR)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$863,947 |
| Sells |
1718 |
$809,200,147 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 27 May 2026 |
ROTHBLATT MARTINE A |
Chairperson & CEO |
26 May 2026 |
1,500 |
575.96 |
863,947 |
| 03 May 2023 |
PATUSKY CHRISTOPHER |
Director |
10 Jun 2019 |
4 |
82.83 |
331 |
| 03 May 2023 |
PATUSKY CHRISTOPHER |
Director |
20 Apr 2018 |
6 |
114.06 |
684 |
| 03 May 2023 |
PATUSKY CHRISTOPHER |
Director |
20 Nov 2017 |
5 |
126.20 |
631 |
| 03 May 2023 |
PATUSKY CHRISTOPHER |
Director |
28 Jul 2017 |
3 |
128.35 |
385 |
| 03 May 2023 |
PATUSKY CHRISTOPHER |
Director |
17 Jul 2017 |
3 |
130.24 |
391 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock